SERIAL #98471236
LIVE

Serial Number

98471236

Owner

Abbott Laboratories

Attorney

Jennifer M. Mikulina

Filing Date

Mar 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98471236 Trademark

Serial Number: 98471236

Serial #98471236 is a trademark filed by Abbott Laboratories on March 27, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Abbott Laboratories

100 Abbott Park Road
Abbott Park, IL 60064

Entity Type: 03

Trademark Details

Filing Date

March 27, 2024

Registration Date

Not Registered

Published for Opposition

February 18, 2025

Goods & Services

Medical diagnostic instruments for diabetes diagnosis and monitoring; medical diagnostic instruments for analyzing, measuring and testing blood, bodily fluids and tissue; medical diagnostic instruments for in vitro diagnostic testing and analysis, namely, sample handlers, sample preparation equipment, equipment for testing bodily fluids for medical diagnosis; medical diagnostic instruments for microbial screening and identification, analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and pathogens; medical and surgical apparatus and instruments, namely, stents, catheters, guide wires, bioabsorbable stents, drug-eluting stents, scaffolding for catheters and stents for use in vascular procedures; medical apparatus and equipment, namely, patient monitor that is for use in electronic acquisition, capture and transmission of medical device status and patient medical and physiological data used in connection with implantable cardiac devices, and external or implantable cardiac therapeutic or diagnostic devices; medical diagnostic instruments for testing patients for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic apparatus and incorporated recorded computer software for analyzing medical data and informing treatment decisions, all sold as a unit, for medical diagnostic use; medical apparatus and instruments, namely, blood glucose meters, blood ketone meters, biosensors and biosensor applicators for measuring blood glucose, blood ketone, and blood lactate levels, electrochemical sensors for measuring analyte concentrations in interstitial fluid, electrochemical sensors for monitoring analyte levels in interstitial fluid, electrochemical sensors for monitoring analyte concentrations in bodily fluids, electrochemical sensors for monitoring analyte levels in bodily fluids, electrochemical sensors for monitoring analytes in bodily fluids, needles for injecting insulin, medical infusion pumps for delivering measured amounts of solutions into the bloodstream over time, and insulin pumps; blood, bodily fluid, tissue, and fecal matter medical testing instruments; medical apparatus for monitoring, tracking, and determining analyte concentrations; sensors for monitoring, tracking, and determining analyte concentrations for health purposes; medical apparatus and instruments for monitoring glucose; medical apparatus and instruments for monitoring ketones; instruments and apparatus for monitoring glucose for health purposes; instruments and apparatus for monitoring ketones for health purposes; patient monitoring sensors for monitoring glucose concentrations; patient monitoring sensors for monitoring ketone concentrations; sensor-based glucose monitors for medical purposes; sensor-based ketone monitors for medical purposes; medical devices, namely, catheters and catheter interface modules; medical and surgical catheters; enteral nutritional delivery system, namely, feeding tubes; breastmilk storage bottle; infant formula storage bottle, sold empty; baby bottles; baby nursers

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 1, 2026 EXRA
SOU EXTENSION 2 GRANTED
Mar 31, 2026 EX2G
SOU EXTENSION 2 FILED
Mar 31, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 31, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 18, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 18, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 18, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 15, 2025 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 15, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 9, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2025 CNEA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2025 CNEA
ASSIGNED TO EXAMINER
Dec 23, 2024 DOCK
ASSIGNED TO EXAMINER
Dec 23, 2024 DOCK
ASSIGNED TO EXAMINER
Nov 30, 2024 DOCK
ASSIGNED TO EXAMINER
Nov 30, 2024 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 24, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 24, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 24, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2024 DOCK
ASSIGNED TO EXAMINER
Oct 16, 2024 DOCK
ASSIGNED TO EXAMINER
Oct 8, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2024 NWOS
NEW APPLICATION ENTERED
Mar 27, 2024 NWAP